Breakthrough · April 21, 2026
Thailand Approves First Domestically Developed Cancer Drug for Clinical Use
Thailand has developed a homegrown cancer drug breakthrough, advancing treatment options and demonstrating medical innovation....
Pediatrics · April 10, 2026
Open Science Project Advances Potential Therapy for Rare Childhood Brain Cancer
UNC pharmacy researchers are making progress toward breakthrough treatments for pediatric brain cancer....
Breakthrough · March 29, 2026
FDA Shifts Drug Approval Standard to Single Clinical Trial for Most New Medicines
FDA's removal of dual-study requirement expedites drug approvals and speeds life-saving treatments to patients....
Research · March 27, 2026
Drug Trial Success Rates Show Signs of Recovery After Decades of Decline
Analysis of clinical trial success rates in the 21st century provides insights for improving drug development and approval process...
Breakthrough · March 24, 2026
FDA Approves First AI-Directed Cancer Therapy and Streamlines Drug Development Paths
FDA actions in 2026 are reshaping drug development to accelerate the pathway for new treatments to reach patients....
Cancer · March 23, 2026
New FDA Guidance Accelerates Myeloma Drug Approvals and Patient Access
Researchers achieve significant progress in developing new myeloma treatments....
Research · March 19, 2026
New Alzheimer's Research Chair Established Through Major Funding Partnership
New partnership expands Alzheimer's research capabilities and potential treatments....
Breakthrough · March 2, 2026
Alzheimer's Drug Development Emerges From Long Period Of Setbacks
Major innovation breakthrough achieved in Alzheimer's disease pharmaceutical development....
Breakthrough · February 19, 2026
FDA To Allow Single-Study Drug Approvals In Bid To Speed New Treatments
FDA streamlines drug approval process with single-study requirement, potentially bringing life-saving treatments to patients faste...
Cancer · January 2, 2026
FDA Approves Six Novel Cancer Therapies In Landmark Month For Oncology
Six new cancer therapies approved by FDA in December 2025, expanding hope for cancer patients....
Treatment · January 2, 2026
FDA Approves 46 New Drugs in 2025 as Treatment Options Expand
A comprehensive overview of 2025 FDA approvals highlights numerous new treatment options for patients....
Breakthrough · December 2, 2025
FDA Grants Priority Review to New Hypertension Drug for Treatment-Resistant Cases
Baxdrostat receives FDA priority review as a promising new option for patients struggling to control hypertension....